Esketamine Combined With Pregabalin on CPSP in Spinal Patients.

Clinical trial NCT06117917 · UNKNOWN

Trial details

NCT number: NCT06117917
Sponsor: Beijing Tiantan Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Esketamine Pregabaline Chronic Post Operative Pain

Start date: 2023-11-10
Primary completion: 2024-05-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.